Pfizer Confirms EU Pegfilgrastim Launch Plans

Follows Formal European Commission Approval For Nyvepria Biosimilar

 
• By Dave Wallace

Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.

Red_Rocket
Pfizer has confirmed a launch window for its Nyvepria pegfilgrastim biosimilar • Source: Shutterstock

More from Archive

More from Generics Bulletin